TY - JOUR
T1 - Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis
AU - Perrino, Melissa R.
AU - Jongmans, Marjolijn C.J.
AU - Tomlinson, Gail E.
AU - Greer, Mary Louise C.
AU - Scollon, Sarah R.
AU - Mitchell, Sarah G.
AU - Hansford, Jordan R.
AU - Schultz, Kris Ann P.
AU - Kohlmann, Wendy K.
AU - Kalish, Jennifer M.
AU - MacFarland, Suzanne P.
AU - Das, Anirban
AU - Maxwell, Kara N.
AU - Pfister, Stefan M.
AU - Weksberg, Rosanna
AU - Michaeli, Orli
AU - Tabori, Uri
AU - Ney, Gina M.
AU - Lupo, Philip J.
AU - Brzezinski, Jack J.
AU - Stewart, Douglas R.
AU - Woodward, Emma R.
AU - Kratz, Christian P.
N1 - ©2025 American Association for Cancer Research.
PY - 2025/4/15
Y1 - 2025/4/15
N2 - Schwannomatosis (SWN) is a distinct cancer predisposition syndrome caused by germline pathogenic variants in the genes NF2, SMARCB1, or LZTR1. There is a significant clinical overlap between these syndromes with the hallmark of increased risk for cranial, spinal, and peripheral schwannomas. Neurofibromatosis type 2 was recently renamed as NF2-related SWN and is the most common SWN syndrome, with increased risk for bilateral vestibular schwannomas, intradermal schwannomas, meningiomas, and less commonly, ependymoma. SMARCB1-related SWN is a familial SWN syndrome associated with peripheral and spinal schwannomas and an increased risk for meningiomas and malignant peripheral nerve sheath tumors, even in the absence of radiation. These individuals do not develop bilateral vestibular schwannomas. Finally, patients with LZTR1-related SWN typically present with peripheral schwannomas, and unilateral vestibular schwannomas have been reported. The following perspective is intended to highlight the clinical presentation and international tumor surveillance recommendations across these SWN syndromes.
AB - Schwannomatosis (SWN) is a distinct cancer predisposition syndrome caused by germline pathogenic variants in the genes NF2, SMARCB1, or LZTR1. There is a significant clinical overlap between these syndromes with the hallmark of increased risk for cranial, spinal, and peripheral schwannomas. Neurofibromatosis type 2 was recently renamed as NF2-related SWN and is the most common SWN syndrome, with increased risk for bilateral vestibular schwannomas, intradermal schwannomas, meningiomas, and less commonly, ependymoma. SMARCB1-related SWN is a familial SWN syndrome associated with peripheral and spinal schwannomas and an increased risk for meningiomas and malignant peripheral nerve sheath tumors, even in the absence of radiation. These individuals do not develop bilateral vestibular schwannomas. Finally, patients with LZTR1-related SWN typically present with peripheral schwannomas, and unilateral vestibular schwannomas have been reported. The following perspective is intended to highlight the clinical presentation and international tumor surveillance recommendations across these SWN syndromes.
KW - SMARCB1 Protein/genetics
KW - Genetic Predisposition to Disease
KW - Neurofibromin 2/genetics
KW - Humans
KW - Neurilemmoma/genetics
KW - Transcription Factors/genetics
KW - Central Nervous System Neoplasms/diagnosis
KW - Child
KW - Neurofibromatoses/genetics
KW - Skin Neoplasms/genetics
KW - Neurofibromatosis 2/genetics
UR - https://www.scopus.com/pages/publications/105003577188
UR - https://www.mendeley.com/catalogue/2cf83c0c-cb52-36bc-917b-8443d5e23521/
U2 - 10.1158/1078-0432.CCR-24-3278
DO - 10.1158/1078-0432.CCR-24-3278
M3 - Article
C2 - 39937237
AN - SCOPUS:105003577188
SN - 1078-0432
VL - 31
SP - 1400
EP - 1406
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 8
ER -